Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese

Journal of the Neurological Sciences

Volumn 276, Issue 1-2, 2009, Pages 118-122

  Wang, Bin ^a   Zhao, Hongye ^a   Zhou, Li ^a   Dai, Xiaoxia ^b   Wang, Dayu ^c   Cao, Jun ^d   Niu, Wenquan ^e  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

^b The First Hospital of Qiqihar   (China)

^c Occupational Disease Department   (China)

^d INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^e SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Apolipoprotein E; Haplotype; Hypertension; Interaction; Ischemic stroke; Lipid profile; Low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN E; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINA; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOSPITAL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, LDL; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 58149233787     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.09.013     Document Type: Article

References (43)

1. Fazel P., and Johnson K. Current role of medical treatment and invasive management in carotid atherosclerotic disease. Proc (Bayl Univ Med Cent) 21 (2008) 133-138
2. Hassan A., and Markus H.S. Genetics and ischaemic stroke. Brain 123 (2000) 1784-1812
3. Hademenos G.J., Alberts M.J., Awad I., Mayberg M., Shepard T., Jagoda A., et al. Advances in the genetics of cerebrovascular disease and stroke. Neurology 56 (2001) 997-1008
4. Tirschwell D.L., Smith N.L., Heckbert S.R., Lemaitre R.N., Longstreth Jr. W.T., and Psaty B.M. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63 (2004) 1868-1875
5. Kurth T., Everett B.M., Buring J.E., Kase C.S., Ridker P.M., and Gaziano J.M. Lipid levels and the risk of ischemic stroke in women. Neurology 68 (2007) 556-562
6. Staessen J.A., Gasowski J., Wang J.G., Thijs L., Den Hond E., Boissel J.P., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 355 (2000) 865-872
7. Gorelick P.B. New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 1 (2002) 149-156
8. Tirschwell D.L., Smith N.L., Heckbert S.R., Lemaitre R.N., Longstreth Jr. W.T., and Psaty B.M. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63 (2004) 1868-1875
9. Amarenco P., Labreuche J., Lavallee P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
10. Amarenco P., Bogousslavsky J., Callahan III A., Goldstein L.B., Hennerici M., Rudolph A.E., et al. Stroke prevention by aggressive reduction in cholesterol levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
11. Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8 (1988) 1-21
12. Dammerman M., and Breslow J.L. Genetic basis of lipoprotein disorders. Circulation 91 (1995) 505-512
13. Van Eck M., Van Dijk K.W., Herijgers N., Hofker M.H., Groot P.H., and Van Berkel T.J. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis. Atherosclerosis 154 (2001) 103-112
14. Li L., Thompson P.A., and Kitchens R.L. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res (2008; May 22) [Epub ahead of print]
15. Dallongeville J., Lussier-Cacan S., and Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33 (1992) 447-454
16. Hegele R.A., Brunt J.H., and Connelly P.W. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol 15 (1995) 861-871
17. Boright A.P., Connelly P.W., Brunt J.H., Morgan K., and Hegele R.A. Association and linkage of LDLR gene variation with variation in plasma low density lipoprotein cholesterol. J Hum Genet 43 (1998) 153-159
18. Luthra K., Prasad K., Kumar P., Dwivedi M., Pandey R.M., and Das N. Apolipoprotein E gene polymorphism in cerebrovascular disease: a case-control study. Clin Genet 62 (2002) 39-44
19. Frikke-Schmidt R., Nordestgaard B.G., Schnohr P., and Tybjaerg-Hansen A. Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke. A case-control and prospective study. Eur Heart J 25 (2004) 943-951
20. Pezzini A., Grassi M., Del Zotto E., Bazzoli E., Archetti S., Assanelli D., et al. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke 35 (2004) 438-442
21. Fu Y., Katsuya T., Higaki J., Asai T., Fukuda M., Takiuchi S., et al. A common mutation of low-density lipoprotein receptor gene is associated with essential hypertension among Japanese. J Hum Hypertens 15 (2001) 125-130
22. Zapata C., Carollo C., and Rodriguez S. Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 65 (2001) 395-406
23. Smith N.L., Hindorff L.A., Heckbert S.R., Lemaitre R.N., Marciante K.D., Rice K., et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 297 (2007) 489-498
24. Utermann G., Hees M., and Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269 (1977) 604-607
25. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17 (1998) 14-20
26. McCarron M.O., Delong D., and Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 53 (1999) 1308-1311
27. Mahley R.W., and Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1 (2000) 507-537
28. Brewer H.B., Zech L.A., Gregg R.E., Schwartz D., and Schaefer E.J. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med 98 (1983) 623-640
29. Yang R., Powell-Braxton L., Ogaoawara A.K., Dybdal N., Bunting S., Ohneda O., et al. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 19 (1999) 2762-2768
30. Kesäniemi Y.A., Ehnholm C., and Miettinen T.A. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80 (1987) 578-581
31. Sing C.F., and Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37 (1985) 268-285
32. Margaglione M., Seripa D., Gravina C., Grandone E., Vecchione G., Cappucci G., et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke 29 (1998) 399-403
33. Peng D.Q., Zhao S.P., and Wang J.L. Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk 6 (1999) 1-6
34. Woo D., Kaushal R., Chakraborty R., Woo J., Haverbusch M., Sekar P., et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 36 (2005) 1874-1879
35. Catto A.J., McCormack L.J., Mansfield M.W., Carter A.M., Bamford J.M., Robinson P., et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 101 (2000) 399-404
36. Frikke-Schmidt R., Nordestgaard B.G., Thudium D., Moes Gronholdt M.L., and Tybjaerg-Hansen A. APOE genotype predicts AD and dementia but not ischemic cerebrovascular disease. Neurology 56 (2001) 194-200
37. Topic E., Timundic A.M., Ttefanovic M., Demarin V., Vukovic V., Lovrencic-Huzjan A., et al. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease. Clin Chem Lab Med 39 (2001) 346-350
38. Kokubo Y., Chowdhury A.H., Date C., Yokoyama T., Sobue H., and Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 31 (2000) 1299-1306
39. Aalto-Setala K., Palomaki H., Miettinen H., Vuorio A., Kuusi T., Raininko R., et al. Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med 30 (1998) 224-233
40. Liu N., Zhang K., and Zhao H. Haplotype-association analysis. Adv Genet 60 (2008) 335-405
41. Tonk M., and Haan J. A review of genetic causes of ischemic and hemorrhagic stroke. J Neurol Sci 257 (2007) 273-279
42. Hankey G.J. Potential new risk factors for ischemic stroke: what is their potential?. Stroke 37 (2006) 2181-2188
43. Niu W., Guo X., Su Y., and Qiu C. Apolipoprotein E and low-density lipoprotein receptor gene polymorphisms in dyslipidemias-associated essential hypertension. J Hum Hypertens 21 (2007) 337-339